Review of Randomized Clinical Trials of Drug-Eluting Stents for the Prevention of In-Stent Restenosis††All study acronyms used in this review are defined in Table 1.
- 15 June 2006
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 98 (3) , 375-382
- https://doi.org/10.1016/j.amjcard.2006.02.042
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) TrialJournal of the American College of Cardiology, 2006
- Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vesselsEuropean Heart Journal, 2006
- Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized TrialCirculation, 2005
- Clinical Experiences Using Everolimus‐Eluting Stents in Patients with Coronary Artery DiseaseJournal of Interventional Cardiology, 2004
- Six- and Twelve-Month Results From First Human Experience Using Everolimus-Eluting Stents With Bioabsorbable PolymerCirculation, 2004
- Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery LesionsCirculation, 2003
- TAXUS ICirculation, 2003
- Studies of the binding of actinomycin and related compounds to DNAJournal of Molecular Biology, 1968